Abstract

285P Gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer: A multicenter, single-arm, phase I/II trial

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer
Naminatsu Takahara ... Makoto Ueno
Investigational new drugs | VOL. 41
Naminatsu Takahara, et. al.Naminatsu Takahara ... Makoto Ueno
02 Dec 2022
Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply.
...
The Lancet. Oncology | VOL. 22
, et. al. ...
01 Jul 2021
Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study
Do-Youn Oh ... Jin Won Kim
The Lancet Gastroenterology & Hepatology | VOL. 7
Do-Youn Oh, et. al.Do-Youn Oh ... Jin Won Kim
09 Mar 2022
Phase II study of fruquintinib as second or further-line therapy for patients with advanced biliary tract cancer.
Pengfei Zhang ... Yu Yang
Journal of Clinical Oncology | VOL. 41
Pengfei Zhang, et. al.Pengfei Zhang ... Yu Yang
01 Jun 2023
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
ESMO Clinical Practice Guideline interim update on new targeted therapies in the first-line and at relapse of chronic lymphocytic leukaemia
B Eichhorst ... C Buske
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
B Eichhorst, et. al.B Eichhorst ... C Buske
01 Jul 2024
Proofreading the way: immune checkpoint inhibitors in polymerase ε/polymerase δ (POLE/POLD1)-altered colorectal cancer
M Cecchini ... R Sundar
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
M Cecchini, et. al.M Cecchini ... R Sundar
01 Jul 2024
Table of Contents
-
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
--
01 Jul 2024
View more papers